Neurologic clinical trial - IPSEN Dsyport Study

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT04936542

A Post Marketing, Multicentre, Interventional, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison with OnabotulinumtoxinA (Botox®) 

Drug

Dysport

Phase

Phase IV

Condition

Upper limb Spasticity